Ashwagandha Supplementation for Prevention of Muscle Damage
Launched by UNIVERSITY OF SASKATCHEWAN · Mar 21, 2025
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of an herbal supplement called Ashwagandha on muscle recovery after exercise. Researchers want to find out if taking Ashwagandha for a short period of time can help improve muscle strength, reduce swelling, and lessen soreness in the biceps after working out. The trial is currently looking for participants aged 18 to 35, regardless of gender, who are in generally good health and do not have certain conditions that might be affected by exercise.
If you join this study, you will take Ashwagandha for about 8 to 12 weeks while participating in exercise routines. The researchers will monitor your muscle recovery to see if the supplement helps you feel better after workouts. It's important to note that people who are pregnant, breastfeeding, or have specific allergies to certain ingredients will not be able to participate. This trial could provide valuable insights into how Ashwagandha might help with muscle recovery for active individuals.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: male or female, aged 18-35y
- • -
- Exclusion Criteria:
- • Conditions that may be affected by exercise (determined by "yes" answers to the "Get Active Questionnaire") Pregnant Breastfeeding
- Allergies to:
- • Dicalcium Phosphate
- • Cellulose
- • Vegetable magnesium stearate
- • Silica
About University Of Saskatchewan
The University of Saskatchewan is a leading research institution dedicated to advancing health sciences through innovative clinical trials and studies. With a commitment to improving patient outcomes, the university leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous and ethically sound research. By fostering collaborations among researchers, healthcare professionals, and industry partners, the University of Saskatchewan aims to translate scientific discoveries into practical applications that enhance healthcare delivery and contribute to the well-being of communities both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saskatoon, Saskatchewan, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported